MENU
+Compare
HIMS
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$36.03
Change
-$2.99 (-7.66%)
Capitalization
8.21B

HIMS Hims & Hers Health Forecast, Technical & Fundamental Analysis

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss... Show more

HIMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HIMS with price predictions
Nov 12, 2025

HIMS in downward trend: price dove below 50-day moving average on October 21, 2025

HIMS moved below its 50-day moving average on October 21, 2025 date and that indicates a change from an upward trend to a downward trend. In of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HIMS as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HIMS turned negative on October 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for HIMS crossed bearishly below the 50-day moving average on October 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIMS entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMS advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

HIMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HIMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.124) is normal, around the industry mean (18.827). P/E Ratio (68.019) is within average values for comparable stocks, (71.764). Projected Growth (PEG Ratio) (2.041) is also within normal values, averaging (1.856). HIMS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (4.136) is also within normal values, averaging (39.291).

View a ticker or compare two or three
HIMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HIMS is expected to report earnings to rise 94.50% to 11 cents per share on March 02

Hims & Hers Health HIMS Stock Earnings Reports
Q4'25
Est.
$0.12
Q3'25
Missed
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.06
The last earnings report on November 03 showed earnings per share of 5 cents, missing the estimate of 10 cents. With 34.91M shares outstanding, the current market capitalization sits at 8.21B.
A.I. Advisor
published General Information

General Information

a company, which is involved in real estate investment trusts

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2269 Chestnut Street
Phone
+1 415 851-0195
Employees
658
Web
https://www.forhims.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIDCX8.200.04
+0.49%
Goldman Sachs Intl Eq Div & Prem C
AIORX11.200.05
+0.45%
American Century International Opps R
SCPAX12.210.01
+0.08%
SEI Large Cap Disciplined Eq A (SIIT)
FBIOX24.37N/A
N/A
Fidelity Select Biotechnology
NZDUSD0.57N/A
N/A
New Zealand Dollar - United States Dollar

HIMS and Stocks

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-1.84%
COTY - HIMS
31%
Poorly correlated
+5.60%
EWCZ - HIMS
30%
Poorly correlated
+13.97%
ALKS - HIMS
29%
Poorly correlated
-7.11%
HROW - HIMS
26%
Poorly correlated
-0.77%
TKNO - HIMS
25%
Poorly correlated
-8.98%
More

Groups containing HIMS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-1.84%
Pharmaceuticals: Generic
industry (214 stocks)
39%
Loosely correlated
-1.00%
Pharmaceuticals
industry (378 stocks)
18%
Poorly correlated
-0.99%